MOTS-c
A mitochondrial peptide that tells muscle to burn fuel. More stamina and steadier blood sugar in animals; a few humans. Pulsed dosing.
What it is
MOTS-c is for the person whose training has flattened out, who gasses early in cardio or feels like their metabolism is sluggish, and who wants to work on the engine rather than the appetite. It is a signal your own mitochondria make. Expect better endurance and recovery over a few weeks, not fat loss on its own.
Three kinds of people run it: endurance athletes and masters lifters who want more work capacity per session, people with early insulin resistance who want their muscle to handle glucose better, and the longevity crowd building a mitochondrial stack. It is not a weight-loss peptide in the GLP-1 sense; appetite does not change, and if you are not training it has little to act on.
The first thing most notice, around week two or three, is that the back half of a hard session feels easier and the next day's soreness is lower. Some report steadier energy through the afternoon and fewer post-meal slumps. Fasting glucose and post-meal readings often tick down by week four to six if they were elevated. Good looks like adding reps or minutes without adding effort. It will not move the scale by itself and it will not do anything you can feel at rest in week one; people who quit early mistake quiet for failure.
Two patterns work: 0.5 to 1 mg subQ daily, or 3 mg two or three times a week. The pulsed pattern fits how MOTS-c behaves in the body (it spikes with exercise, then clears) and is what the animal longevity work used, so most experienced users pulse, ideally on training days an hour or so before the session. A 10 mg vial is ten days at 1 mg, or three pulsed doses, so for an 8 to 12 week pulsed run buy the 40 mg vial; at 16 to 36 doses, that run takes two or three of them. One catch: mixed, a 40 mg vial is about 13 pulsed doses, or 4.5 to 6.5 weeks, longer than its 3 to 4 week fridge life, so keep it cold and plan to throw out the last few doses; the daily plan finishes a 10 mg vial in 10 to 20 days, well inside that window. Mix with 1 ml so 10 units is 1 mg. Run 8 to 12 weeks, then a few weeks off. Nothing suggests MOTS-c stops working with use; the break is caution because human data is thin, two to four weeks is plenty, and some people on the pulsed pattern skip cycling altogether. The common mistake is dosing it like BPC, 250 mcg daily, and concluding it does nothing.
The animal data is strong and consistent: MOTS-c activates AMPK, the cell's fuel switch, improving glucose uptake, fat oxidation and running capacity in mice, and reversing age-related decline in some models. In people, the evidence is mostly that MOTS-c levels rise with exercise and fall with age and insulin resistance; there is very little trial data on giving it. So the mechanism is well grounded and the human outcome is extrapolated. Not approved.
If fat loss is the main goal, a GLP-1 does more than MOTS-c ever will. If you want the mitochondrial angle, think of the stack as an engine: MOTS-c is the gas pedal (the signal to burn), NAD+ is the fuel in the tank, and SS-31 is engine efficiency. Start with MOTS-c for metabolism and performance; start with NAD+ for longevity and repair. 5-Amino-1MQ is the other feel-nothing metabolic add-on, and the two are often paired.
What people use it for
Metabolism and insulin sensitivity
Some evidenceIn mice MOTS-c activates AMPK in muscle, increases glucose uptake and fat oxidation, and prevents diet-induced obesity and insulin resistance. In people, circulating MOTS-c is lower with age and insulin resistance, which is why it is studied as a metabolic regulator. Giving it to a person with early insulin resistance is a reasonable bet, backed by mechanism and a little human data, not a trial result.
Exercise capacity
Some evidenceMice given MOTS-c ran longer and recovered faster, including old mice, and the peptide rises in human blood after exercise, so it is part of the normal training response. Users report easier sessions by week two or three. There is no human performance trial, so the effect size in a trained adult is unknown.
Aging and longevity
Early daysIn aged mice, late-life MOTS-c treatment improved physical capacity and some healthspan markers, and the peptide is one of the better-studied mitochondrial-derived peptides in aging research. Whether a few cycles a year do anything measurable to a person's aging is unknown, and nobody is running that trial.
How it works
- Used for energy, metabolism, and exercise capacity
- Comes from your own mitochondria
- Mostly animal research with limited human data
- Promising for metabolic health, but still early
How people use it
Safety, in brief
Things people sometimes notice
- A little redness where you inject
- A temporary dip or surge in energy in the first week as it settles
- Mild stomach upset for some
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.
- The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance
- MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis
- Mitochondrial-Encoded Peptide MOTS-c, Diabetes, and Aging-Related Diseases